Relocation of the Nano and Micro HPLC Systems and the Q Exactive Mass Spectrometer.
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N98026Q01253 in this department, oldest first.
- Sep 24, 2026 · this noticePre-solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
NOTICE OF INTENT � SOLE SOURCE ACQUISITION Notice No.: 75N98026Q01253 The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Thermo Electron for the relocation of the Nano and Micro HPLC Systems and the Q Exactive Mass Spectrometer. The Government intends to solicit from a single source in accordance with FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Description of Requirement The objective of this requirement is to safely relocate the Government's Nano HPLC System, Micro HPLC System, and Q Ex… (show all)
active Mass Spectrometer from a radiochemistry laboratory in Building 10 to the Mass Spectrometry Unit in Building 13. The instruments require specialized disassembly, packaging, transportation preparation, reassembly, and post-relocation diagnostic testing. The relocation must be performed in a manner that protects the instruments from damage and ensures that they remain properly configured and operational following installation at the new location. The required services include, but are not limited to, the following: Provide instrument-specific shipping crates designed and/or approved for the Nano HPLC System, Micro HPLC System, and Q Exactive Mass Spectrometer. Disassemble the Nano HPLC System, Micro HPLC System, and Q Exactive Mass Spectrometer at the Building 10 laboratory. Properly secure and package each instrument in the appropriate instrument-specific crate in preparation for relocation. Provide the technical expertise necessary to safely prepare the instruments for transport. Reassemble and install the instruments at the Building 13 Mass Spectrometry Unit. Perform diagnostic testing and appropriate operational checks following reassembly to verify that the Nano HPLC System, Micro HPLC System, and Q Exactive Mass Spectrometer are functioning properly. Address any installation-related issues identified during post-relocation diagnostic testing. Justification for Sole-Source Acquisition The Government has determined that Thermo Electron is the only known source capable of providing the required relocation services while maintaining the technical and operational integrity of the instruments. The instruments are Thermo Electron-manufactured systems that require specialized knowledge of their configuration, components, connections, disassembly procedures, reassembly procedures, and manufacturer-specific diagnostic requirements. The relocation involves more than ordinary equipment moving services and requires qualified technical personnel capable of disassembling and reassembling the systems without compromising their performance or configuration. The requirement also includes instrument-specific crates designed to protect the Nano HPLC System, Micro HPLC System, and Q Exactive Mass Spectrometer during relocation. The Government requires that the instruments be properly disassembled, secured, transported, reassembled, and diagnostically tested by personnel possessing the necessary technical knowledge and experience with these systems. Use of a general laboratory equipment moving service or an otherwise unqualified third party could introduce a risk of damage, improper reassembly, loss of instrument configuration, or failure to restore the systems to operational status. Such risks could result in additional costs, equipment downtime, and delays to ongoing research activities. Based on the Government's market research and knowledge of the equipment, Thermo Electron possesses the specialized technical expertise and manufacturer-specific knowledge necessary to perform the complete relocation, reassembly, and diagnostic testing of these instruments. Accordingly, the Government believes that Thermo Electron is the only responsible source capable of satisfying the requirement without unacceptable risk to the equipment and associated research operations. Response Information This notice is not a request for competitive quotations. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required services and satisfy all specified technical and operational requirements. Capability statements must specifically address the offeror's: Experience disassembling and reassembling Thermo Electron Nano and Micro HPLC systems and Q Exactive Mass Spectrometers; Availability of qualified technicians with manufacturer-specific training or equivalent documented technical qualifications; Ability to provide appropriate instrument-specific crates or equivalent manufacturer-approved protective packaging; Ability to safely prepare the instruments for transport and reassemble them at the destination laboratory; and Ability to perform post-installation diagnostic and operational testing. The Government will consider all timely capability statements received and will determine whether the acquisition should proceed as a sole-source procurement or be competed. The Government anticipates making an award approximately one (1) calendar day after the closing date of this notice, unless the Government determines that another responsible source is capable of meeting the requirement. Capability statements shall be submitted electronically to haunp@mail.nih.gov no later than 9:00 a.m. EDT on September 28, 2026. Please reference Notice No. 75N98026Q01253 in the subject line of the response.
Who won similar work
258 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (191): middle half $115K to $19.9M, median $1.4M; range $12K to $89.0B.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BECTON, DICKINSON AND COMPANY · $BDX · $22.5B | 4 | $1.9M | Jan 26, 2026 |
| DUKE UNIVERSITY Durham NC 27705 USA | 3 | $36.3M + 1 shared | Dec 21, 2025 |
| Axle Informatics Rockville MD 20852 USA | 3 | $24.5M | May 22, 2025 |
| Axle Informatics, LLC | 3 | $15.4M | Dec 15, 2025 |
| BRUKER BIOSPIN CORP · $BRKR · $3.5B | 3 | $1.7M | Jul 30, 2026 |
| AGILENT TECHNOLOGIES INC · $A · $7.4B | 3 | $445K | Jul 24, 2025 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 3 | $318K | Jan 9, 2026 |
| Multiple_Awards Bethesda MD USA | 2 | $1.1B | Dec 17, 2024 |
| FISHER BIOSERVICES INC | 2 | $148.0M | Oct 7, 2026 |
| Coriell Institute for Medical Research, Inc. | 2 | $58.8M | Aug 1, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $BDX reported $22.5B revenue (12 months to Jun 30, 2026). The median single-winner award in these 191 past awards, $1.4M, is under 0.1% of that. SEC filing
- $BRKR reported $3.5B revenue (12 months to Jun 30, 2026). The median single-winner award in these 191 past awards, $1.4M, is under 0.1% of that. SEC filing
- $A reported $7.4B revenue (12 months to Jul 31, 2026). The median single-winner award in these 191 past awards, $1.4M, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 9, 2026Revvity Health Sciences, Inc.$21KAutomated Cell Counter and AnalyzerNo listed company matched (Materiality N/A)
- Oct 7, 2026PPD DEVELOPMENT LP$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026FISHER BIOSERVICES INC$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESMateriality: 0.10% of $TMO revenue (Low) SEC
- Oct 7, 2026BCG FEDERAL CORP.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026ADVANCED BIOSCIENCE LABORATORIES, INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026SIA PARTNERS U.S., INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Oct 7, 2026AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASESNo listed company matched (Materiality N/A)
- Sep 30, 2026Washington Metropolitan Area Transit Authority Washington DC 20024 USA$23.8MNIH TRANShare Program -WMATA SmartBenefits� Program Transit Benefit ServicesNo listed company matched (Materiality N/A)
- Sep 29, 2026THE BROAD INSTITUTE, INC$215KWhole genome sequencing for investigation of age-related chronic disease in HANDLS participantsNo listed company matched (Materiality N/A)
- Sep 28, 2026EMORY UNIVERSITY 1599 CLIFTON ROAD NE 4TH FLOOR MAILSTOP 1599-001-1BA Atlanta GA 30322 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation StudyShared multiple-award ceiling, not one company's win (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- $45K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 3 of the past winners are listed companies
- 0 insider buys and 5 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.